Biotechnology · Irvine, CA · Founded 2024 · Privately Held (backing)
Operator of a therapeutics company intended to address Complex Regional Pain Syndrome Type 1 (CRPS-1). Ambros Therapeutics is based in Irvine, CA and was founded in 2024. It was valued at $250 million at its early-stage round in Dec 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $154 million Series A in Dec 2025.
PMV mark · valuation
$250.0M
Oct 2026
Priced at
its early-stage round
Dec 2025
Total raised
$154.0M
Last round
Early Stage VC (Series A)
Dec 2025
Team — not yet on record
No current team members for Ambros Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ambros Therapeutics with a free account
·Watch Ambros Therapeutics: the Monday email on marks, rounds and moves
